
Presented by
Management Forum
In this 90-minute webinar, you will gain an insight into the latest updates in GMP, as well as consolidating your existing knowledge on the subject.
Many pharmaceutical manufacturers tend to describe GMP practices as the rules personnel must follow during production and the recording of production steps. However, GMP is a comprehensive set of standards in which every step of all processes, including pharmaceutical production and R&D activities throughout the product life cycle, is validated and documented.
Historical GMP failures have caused significant tragedies for many companies. Today, any country that prioritises patient health and safety permits the production, import, and sale of pharmaceutical products only in compliance with internationally recognised current GMP standards. GMP (Good Manufacturing Practices) is often referenced as cGMP (current Good Manufacturing Practices) in alignment with FDA terminology. The ‘c’ in cGMP stands for ‘current,’ emphasising that these rules are continuously updated and dynamic, rather than following a ‘produce what is available’ approach. Health authorities remind manufacturers that staying up-to-date is a regulatory requirement.
This distinguished GMP Update training covers updates across all sections of the GMP Guide, incorporating innovations from EMA, PIC/S, FDA, WHO, ANVISA, MHRA, and other regulatory bodies. Participants will also explore the latest developments in concept papers, draft articles, and international GMP guidance, ensuring a complete and current understanding of global GMP expectations.
This course is part of ourĀ GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.
This course will also be of interest to:
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to: